Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.

Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
复制标题

DOI:
10.1111/bph.15919
复制
发表时间:
2022-10
影响因子:
7.3
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

我们讨论甲酰肽受体 2(FPR2;通常称为 FPR2/ALX,因为它与脂氧素 A4 结合)的迷人药理学。 FPR2 最初被认为是 FPR1 的低亲和力“亲戚”,具有复杂而多样的生物学特性。例如,它被几类激动剂(从肽到蛋白质和脂质介质)激活,并在骨髓细胞以及上皮细胞和内皮细胞等上显示出不同的表达模式。在过去的十年中,FPR2 的药理学已经从被认为是弱趋化受体发展成为炎症消退(急性炎症反应的第二阶段)的主调节因子。我们认为,利用 FPR2 的生物学特性提供了纠正慢性炎症状态的创新方法,并代表了开发新疗法的可行途径。最近对 FPR2 结构的阐明将有助于未来十年抗炎和促消退药物的开发。
We discuss the fascinating pharmacology of formylpeptide receptor 2 (FPR2; often referred to as FPR2/ALX since it binds lipoxin A4). Initially identified as a low‐affinity ‘relative’ of FPR1, FPR2 presents complex and diverse biology. For instance, it is activated by several classes of agonists (from peptides to proteins and lipid mediators) and displays diverse expression patterns on myeloid cells as well as epithelial cells and endothelial cells, to name a few. Over the last decade, the pharmacology of FPR2 has progressed from being considered a weak chemotactic receptor to a master‐regulator of the resolution of inflammation, the second phase of the acute inflammatory response. We propose that exploitation of the biology of FPR2 offers innovative ways to rectify chronic inflammatory states and represents a viable avenue to develop novel therapies. Recent elucidation of FPR2 structure will facilitate development of the anti‐inflammatory and pro‐resolving drugs of next decade.
DOI: 10.1016/0006-291x(90)91143-g
发表时间: 1990-05-16
影响因子: 3.1
作者:
BOULAY, F;TARDIF, M;VIGNAIS, P
通讯作者: VIGNAIS, P
DOI: 10.1124/mol.64.3.721
发表时间: 2003-09-01
影响因子: 3.6
作者:
Bae, YS;Park, JC;Ryu, SH
通讯作者: Ryu, SH
DOI: 10.4049/jimmunol.1003145
发表时间: 2011-04-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Brancaleone V;Dalli J;Bena S;Flower RJ;Cirino G;Perretti M
通讯作者: Perretti M
DOI: 10.1016/j.bmcl.2006.04.068
发表时间: 2006-07-15
影响因子: 2.7
作者:
Burli, Roland W.;Xu, Han;Hungate, Randall
通讯作者: Hungate, Randall
DOI: 10.1681/asn.2012060550
发表时间: 2013-04-01
影响因子: 13.6
作者:
Brennan, Eoin P.;Nolan, Karen A.;Godson, Catherine
通讯作者: Godson, Catherine